Comprehensive Antibiotic Resistance Website
Country of origin: Canada
Click for Full Details: www.canr.infoThe CAN-R website is aimed at supporting and educating Canadian healthcare providers and researchers on the escalating issue of antimicrobial resistance, bacteria that are resistant to commonly used antibiotics.
The CAN-R website brings together the most current data and information on the surveillance of antibiotic-resistant bacteria in Canada, the use of antimicrobials, clinical guidelines and the latest research on infections caused by antimicrobial-resistant pathogens, as well as existing and investigational treatments
The website features study findings such as the recent CAN-ICU study, which examined the prevalence of superbugs in Canadian intensive care units and identified rates higher than previously believed of antibiotic-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and extended-spectrum beta-lactamases (ESBL).
Dr George Zhanel, Professor, Department of Medical Microbiology, Faculty of Medicine, at the University of Manitoba is leading the website's development as Editor-in-Chief. "This is a very exciting endeavour for Canadian researchers, since until now there has been no other single resource in Canada that provides this level of current and comprehensive information," says Zhanel. "The rise of antibiotic resistance in Canada is of increasing concern to the healthcare community and this new tool will help them stay on top of the issues as they battle these superbugs."
Click for Full Details: www.canr.info
OrthoFlow...the orthopaedic specialist in your pocket! February 2018
Gout Diagnosis February 2018
STD Treatment (Tx) Guidelines mobile app February 2018
UpToDateŽ clinical questions answered February 2018
BMJ Best Practice February 2018
Orlive Surgical Broadcasts February 2018
Pain Information at your fingertips February 2018
myCME, continuing medical education January 2018
Monthly Prescribing Reference January 2018
My PearlPoint Cancer Side Effects January 2018